Search
Medicaid Monitor
Saturday, November 21, 2026 · Updated Fri 12:06 PM MT · 52 stories on Friday, November 20
Medicaid Monitor Pro
Sat, Nov 21 · 52 stories on Friday, November 20PRO
← All stories
IndustryJune 29, 2026

PBM Trade Group Escalates Advocacy Against Drugmakers Following Congressional Overhaul

The leading pharmacy benefit manager lobbying organization is intensifying its advocacy campaign against pharmaceutical manufacturers after Congress enacted comprehensive PBM reform legislation earlier this year. The pharmaceutical industry has long blamed PBMs for high drug costs, culminating in legislative action this past winter. The lobbying escalation suggests ongoing tension between PBMs and drugmakers over responsibility for drug pricing and the implementation of new federal oversight provisions that affect both sectors.

Why it mattersPBM reform implementation will directly affect Medicaid managed care pharmacy contracts, rebate structures, and drug cost transparency requirements that MCOs must navigate with their PBM vendors.

Pharmacy · Managed Care

Read the full article at thehill.com →
Share this briefing

You might also like

← All stories

Get the daily briefing.